Carl Zeiss Meditec AG

CZMWY | OTC

Price Alert Chart Builder DCF Calculator

$33.27

-$1.23 (-3.57%)

At close: Sep 17, 2026, 3:58 PM ET

$33.34

+$0.07 (+0.21%)

After-hours: Sep 17, 2026, 3:35 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Market Data

Market Cap $3.02B

Enterprise Value $2.55B

Beta 1.47

Average Volume N/A

Shares Outstanding (Diluted) 86.3M

Shares Change YoY -1%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M -8.8%

Price Change 3M 6.6%

Price Change 6M 21.4%

Price Change YTD -28.3%

Price Change 1Y -36.1%

Price Change 3Y -61.5%

Price Change 5Y -85.1%

1M CAGR (ann.) -3.5%

1Y CAGR (ann.) -30.7%

5Y CAGR (ann.) -30.7%

All-Time CAGR 8.1%

Valuation

PE Ratio 17.29

Forward PE 20.46

PEG Ratio -5.23

Forward PEG 1.42

PS Ratio 0.94

Forward PS 1.10

PB Ratio 1.21

P/FCF Ratio 9.26

P/Adj. FCF Ratio 9.26

P/OCF Ratio 8.20

EV/Sales 0.96

EV/EBIT 10.57

EV/EBITDA 6.22

EV/FCF 9.46

Earnings Yield 5.7%

FCF Yield 10.6%

Adj. FCF Yield 10.6%

Financial Health

Net Debt €0

Total Debt €0

Cash & Short-Term Investments €23.9M

Total Assets €0

Current Ratio 0.00

Quick Ratio 0.00

Debt / Equity Ratio 0.00

Debt / EBITDA 0.00

Debt / FCF 0.00

OCF / Debt N/A

Interest Coverage 5.27

Altman Z-Score 0.00

Piotroski F-Score 4

Margins & Profitability

Gross Profit Margin 51.0%

Operating Profit Margin 6.4%

EBITDA Margin 12.5%

Net Profit Margin 4.4%

FCF Margin 10.1%

Adj. FCF Margin 10.1%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets 0.0%

Return on Equity 5.5%

Return on Invested Capital 0.0%

Return on Capital Employed 0.0%

Return on Tangible Assets 0.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 8.6%

Revenue CAGR 5Y 11.2%

Revenue CAGR 10Y 9.3%

EPS CAGR 3Y -25.6%

EPS CAGR 5Y -9.0%

EPS CAGR 10Y 5.7%

FCF CAGR 3Y 37.5%

FCF CAGR 5Y -1.8%

FCF CAGR 10Y 9.5%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 16.5%

Revenue Growth Next 3Y -1.2%

Earnings Date Dec 9, 2026

EPS Estimate (next Q) $1.58

EPS Growth Est (next Q) 31.4%

Revenue Est (next Q) $1.23B

Revenue Growth Est (next Q) 45.2%

Fair Value Estimates

Graham Number $34.40

Graham Upside 3.4%

Lynch Fair Value $9.62

Lynch Upside -71.1%

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow €298.89M

Free Cash Flow €269.59M

Adj. Free Cash Flow €269.59M

FCF Per Share $3.16

OCF Per Share $3.48

OCF/S Ratio 11.3%

Income Statement

Revenue €2.66B

Gross Profit €1.64B

Operating Income €169.25M

EBITDA €409.69M

Net Income €116.81M

EPS (Diluted) $1.65

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A

Dividends

Annual Dividend $0.63

Dividend Yield 1.89%

Payout Ratio 38.1%

FCF Payout Ratio 19.6%

Adj. FCF Payout Ratio 19.6%

Dividend Growth (YoY) -2.6%

Pay Frequency Annual

Ex-Dividend Date Mar 29, 2026